The CXCR2 receptor is targeted in cancer. Name five antagonists.
['CXCR2 small-molecule antagonist (SB225002)', 'G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.', 'The CXCR2 antagonist, SCH-527123, shows antitumor activity', 'retreatment with the CXCR2 antagonist AZ10397767', 'The aim of this study was to investigate whether the CXCR2 antagonist, SCH-527123, inhibits colorectal cancer proliferation and if it can sensitize colorectal cancer cells to oxaliplatin both in vitro and in vivo.', 'we report that targeting CXCR2 and CXCR1 activity using orally active small molecule antagonist (SCH-527123, SCH-479833) inhibits human colon cancer liver metastasis mediated by decreased neovascularization and enhanced malignant cell apoptosis.', 'CXCR2-specific small molecule inhibitor (AZ10397767) to investigate the recruitment and function of human neutrophils in tumors']
['There are numerous CXCR2 receptor antagonists, such as SB225002, G31P, SCH-527123, AZ10397767, SCH-479833.']
['SB225002', 'G31P', 'SCH-527123', 'AZ10397767', 'SCH-479833']